Table 3. Risk factors associated with the presence of NAFLD.

Variables	β	SE	Wald χ2	P	OR (95% CI)
Age (year)	0.028	0.003	79.970	<0.001	1.028 (1.022–1.035)
Male gender	0.549	0.106	26.884	<0.001	1.731 (1.407–2.129)
Body mass index (kg/m2)	0.284	0.018	248.144	<0.001	1.328 (1.282–1.376)
Waist circumference (cm)	0.039	0.006	41.316	<0.001	1.040 (1.028–1.053)
Diastolic blood pressure (mmHg)	0.025	0.005	28.278	<0.001	1.025 (1.016–1.034)
ALT/AST ratio	1.649	0.107	235.661	<0.001	5.201 (4.213–6.419)
γ-Glutamyltransferase (U/L)	0.005	0.001	18.993	<0.001	1.005 (1.003–1.008)
Albumin (g/L)	0.081	0.015	30.619	<0.001	1.084 (1.054–1.116)
Triglyceride (mmol/L)	0.214	0.055	15.234	<0.001	1.238 (1.112–1.379)
Total cholesterol (mmol/L)	0.156	0.049	9.944	0.002	1.169 (1.061–1.288)
HDL cholesterol (mmol/L)	−1.352	0.171	62.530	<0.001	0.259 (0.185–0.362)
Fasting plasma glucose (mmol/L)	0.123	0.034	12.925	<0.001	1.131 (1.058–1.209)
Serum uric acid (μmol/L)	0.003	0.001	44.775	<0.001	1.003 (1.002–1.004)
White blood cell (×109/L)	0.064	0.024	6.923	0.009	1.066 (1.016–1.118)
Platelet count (×109/L)	0.003	0.001	20.754	<0.001	1.003 (1.002–1.005)
Serum complement C3 (g/L)	1.655	0.256	41.869	<0.001	5.231 (3.169–8.635)

β, partial regression coefficient; SE, standard error of partial regression coefficient; OR, odds ratio; CI, confidence interval; HDL, high-density lipoprotein.